Finally, while numerous studies have categorized non-synonymous mutations functionally, CRISPR/Cas9 paired with sensitive readouts also opens new avenues to study potential functional deficits of synonymous or non-coding variants in PINK1, PRKN, or other mitophagy genes to determine their pathogenic role for PD. This evidence concerns the gene PINK1 and Parkinson disease.